PROTAC-based NSD2 degrader (University of Alabama/Northwestern University)

N/A

Report date: 2025/06/11 11:18:51

Base Information

Drug NamePROTAC-based NSD2 degrader (University of Alabama/Northwestern University)
Drug Alias NameNUCC-0227383
ClassificationBiologics
Mechanisms of ActionHistone-lysine N-methyltransferase NSD2 inhibitors
TargetsHistone-lysine N-methyltransferase NSD2
Therapy Area/IndicationsHead and Neck NeoplasmsCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Alabama At BirminghamNorthwestern University
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A